WHO ICTRP trial
Chemotherapy-induced peripheral neuropathy; its impact on colorectal cancer…
NL-OMON43710 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON43710 |
|---|---|
| Public title | Chemotherapy-induced peripheral neuropathy; its impact on colorectal cancer patients' lives |
| Scientific title | Chemotherapy-induced peripheral neuropathy; its impact on colorectal cancer patients' lives - The PROCORE study |
| Primary sponsor | Integraal Kankercentrum Nederland, locatie Eindhoven |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Observational invasive |
| Countries | The Netherlands |
| Conditions | Colorectal cancer; colorectal carcinoma;10017990;10017991;Colorectal cancer; colorectal carcinoma |
| Interventions | ;-chemotherapy;-Chemotherapy-induced peripheral neuropathy;-Colorectal cancer;-patient-reported outcomes |
| Registration date | Jun 21, 2016 |
| Target size | 800 |
| Secondary IDs | NL51119.060.14 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: